← Back to Search

Health Information Technology for Dementia Care

N/A

Waitlist Available

Research Sponsored by Florida International University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

21 years-old or older

Care recipients must be 60 years or older

Must not have

Care recipients with significant visual or hearing impairment

Caregivers not speaking and reading English or Spanish

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, 3 months, 6 months

Awards & highlights

No Placebo-Only Group

Summary

This trial will develop and design a personalized AAC device that relies on information technology (IT) and touchscreens to promote communication and personhood for PWD about their care preferences and experiences.

Who is the study for?

This trial is for adults over 21 who care for someone with Alzheimer's or dementia, providing at least 2 hours of daily care. Participants must have internet access and speak English or Spanish. It includes people with neurocognitive disorders aged 60+, scoring ≤21 on a mental status exam, but excludes caregivers planning to quit soon, those caring for individuals in facilities, or anyone with major medical conditions themselves.

What is being tested?

The study tests an Assistive and Alternative Communication (AAC) device integrated into the CareHeroes health IT system to enhance communication between patients with dementia, their caregivers, and healthcare providers over a period of 12 months.

What are the potential side effects?

Since this intervention involves information technology rather than medication, traditional side effects are not expected. However, participants may experience challenges related to using new technology or emotional impacts from changes in communication patterns.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 21 years old or older.

Select...

I am 60 years old or older.

Select...

I am a caregiver and I speak English or Spanish.

Select...

I have been diagnosed with a brain function disorder.

Select...

I can speak and understand English or Spanish.

Select...

I can complete the vision screening test.

Select...

I can speak and understand either English or Spanish.

Select...

I can speak and understand either English or Spanish.

Select...

I am 60 years old or older.

Select...

I have been diagnosed with a specific type of dementia.

Select...

I provide daily care for someone with Alzheimer's or dementia for 2+ hours.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I have a significant hearing or vision impairment.

Select...

My caregiver does not speak or read English or Spanish.

Select...

I have been diagnosed with schizophrenia.

Select...

I am planning to place the person I care for in a long-term care facility soon.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, 3-months, 6-months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, 3-months, 6-months

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 3-months, 6-months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Change in Perceived Change Index- Caregiver QOL

Change in Quality of Life In Alzheimer's disease- Care Recipient and Caregiver (proxy-interview)

Secondary study objectives

Change in 12 Item Short-Form Health Survey (SF-12) - Caregiver

Change in Functional Linguistic Communication Inventory (FLCI)- Care Recipient

Change in Geriatric Depression Scale (GDS-15)- Care Recipient

+9 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Full InterventionExperimental Treatment1 Intervention

Dyads (caregiver, PWD) randomly assigned to the experimental arm will have access to the newly developed My PATI app. Providers' will receive information via the app.

Group II: Usual CareActive Control1 Intervention

Dyads (caregiver, PWD) randomly assigned to the usual care condition will receive usual care from the memory clinic.

0 / 15Eligibility criteria met